Found: 32
Select item for more details and to access through your institution.
Gene therapy via inducible nitric oxide synthase: a tool for the treatment of a diverse range of pathological conditions.
- Published in:
- Journal of Pharmacy & Pharmacology, 2008, v. 60, n. 8, p. 999, doi. 10.1211/jpp.60.8.0007
- By:
- Publication type:
- Article
Targeting nitric oxide for cancer therapy.
- Published in:
- Journal of Pharmacy & Pharmacology, 2007, v. 59, n. 1, p. 3, doi. 10.1211/jpp.59.1.0002
- By:
- Publication type:
- Article
Dexamethasone promotes breast cancer stem cells in obese and not lean mice.
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 2, p. 1, doi. 10.1002/prp2.923
- By:
- Publication type:
- Article
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 4091, doi. 10.3390/ijms22084091
- By:
- Publication type:
- Article
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer.
- Published in:
- Cancer Nanotechnology (1868-6958), 2018, v. 9, n. 1, p. 1, doi. 10.1186/s12645-018-0040-x
- By:
- Publication type:
- Article
Vasoactivity of Rucaparib, a PARP-1 Inhibitor, is a Complex Process that Involves Myosin Light Chain Kinase, P2 Receptors, and PARP Itself.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0118187
- By:
- Publication type:
- Article
The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055075
- By:
- Publication type:
- Article
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 395, doi. 10.3390/biom13020395
- By:
- Publication type:
- Article
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1148934
- By:
- Publication type:
- Article
Precision Oncology, Artificial Intelligence, and Novel Therapeutic Advancements in the Diagnosis, Prevention, and Treatment of Cancer: Highlights from the 59th Irish Association for Cancer Research (IACR) Annual Conference.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1989, doi. 10.3390/cancers16111989
- By:
- Publication type:
- Article
Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual Conference.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6213, doi. 10.3390/cancers14246213
- By:
- Publication type:
- Article
Characterizing and Exploiting Tumor Microenvironments to Optimize Treatment Outcomes.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5752, doi. 10.3390/cancers13225752
- By:
- Publication type:
- Article
Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1649, doi. 10.3390/cancers13071649
- By:
- Publication type:
- Article
Obesity and Cancer Metastasis: Molecular and Translational Perspectives.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3798, doi. 10.3390/cancers12123798
- By:
- Publication type:
- Article
The contribution of N<sub>2</sub>O<sub>3</sub> to the cytotoxicity of the nitric oxide donor DETA/NO: an emerging role for S-nitrosylation.
- Published in:
- Bioscience Reports, 2013, v. 33, n. 2, p. 333, doi. 10.1042/BSR20120120
- By:
- Publication type:
- Article
Pericytes influence endothelial cell growth characteristics: Role of plasminogen activator inhibitor type 1 (PAI-1)
- Published in:
- Cardiovascular Research, 2006, v. 69, n. 1, p. 207, doi. 10.1016/j.cardiores.2005.08.003
- By:
- Publication type:
- Article
Effect of the Rehabilitation Program, ReStOre, on Serum Biomarkers in a Randomized Control Trial of Esophagogastric Cancer Survivors.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.669078
- By:
- Publication type:
- Article
FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.650328
- By:
- Publication type:
- Article
Alterations in the steroid hormone receptor co-chaperone FKBPL are associated with male infertility: a case-control study.
- Published in:
- Reproductive Biology & Endocrinology, 2010, v. 8, p. 22, doi. 10.1186/1477-7827-8-22
- By:
- Publication type:
- Article
Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 1, p. 40, doi. 10.1038/sj.cgt.7700522
- By:
- Publication type:
- Article
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 4, p. 760, doi. 10.1002/ijc.23418
- By:
- Publication type:
- Article
FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cytochrome P450 1B1 mRNA untranslated regions interact to inhibit protein translation.
- Published in:
- Molecular Carcinogenesis, 2010, v. 49, n. 2, p. 190, doi. 10.1002/mc.20589
- By:
- Publication type:
- Article
Cytochrome P450 1B1 expression in rat esophageal tumorigenesis promoted by gastric and duodenal reflux.
- Published in:
- Molecular Carcinogenesis, 2009, v. 48, n. 2, p. 110, doi. 10.1002/mc.20459
- By:
- Publication type:
- Article
FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-78676-6
- By:
- Publication type:
- Article
Gamma Irradiation and Targeted Radionuclides Enhance the Expression of the Noradrenaline Transporter Transgene Controlled by the Radio-Inducible p21<sup>WAF1/CIP1</sup> Promoter.
- Published in:
- Radiation Research, 2013, v. 179, n. 3, p. 282, doi. 10.1667/RR3030.1
- By:
- Publication type:
- Article
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer.
- Published in:
- Journal of Gene Medicine, 2010, v. 12, n. 9, p. 755, doi. 10.1002/jgm.1495
- By:
- Publication type:
- Article
Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells.
- Published in:
- Journal of Gene Medicine, 2009, v. 11, n. 2, p. 160, doi. 10.1002/jgm.1280
- By:
- Publication type:
- Article
Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
- Published in:
- Journal of Gene Medicine, 2007, v. 9, n. 6, p. 511, doi. 10.1002/jgm.1045
- By:
- Publication type:
- Article
A cytochrome P450 2B6 meditated gene therapy strategy to enhance the effects of radiation or cyclophosphamide when combined with the bioreductive drug AQ4N.
- Published in:
- Journal of Gene Medicine, 2005, v. 7, n. 7, p. 851, doi. 10.1002/jgm.728
- By:
- Publication type:
- Article
Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 6, p. 1503, doi. 10.3390/cells9061503
- By:
- Publication type:
- Article
Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program.
- Published in:
- 2016
- By:
- Publication type:
- journal article